Eszopiclone's Role in Treating Primary Insomnia
Insomnia is a common sleep disorder affecting up to 30% of adults, with primary insomnia—difficulty initiating or maintaining sleep not directly caused by another medical or psychiatric condition—being particularly challenging to manage. In recent years, Eszopiclone uk online , a non-benzodiazepine hypnotic agent, has gained recognition as a safe and effective option for treating this condition. Marketed under the brand name Lunesta, Eszopiclone Tablets UK is one of the few medications approved for long-term management of chronic insomnia. This article explores Eszopiclone’s role in treating primary insomnia, examining its mechanism of action, clinical efficacy, advantages, and key considerations for use. What Is Primary Insomnia? Primary insomnia is characterized by: Difficulty falling asleep Trouble staying asleep Waking up too early Poor sleep quality Unlike secondary insomnia, it is not linked to a specific medical, psychiatric, or environmental cause. It can persist for mont...